JSPR
Jasper Therapeutics Inc

3,092
Mkt Cap
$52.33M
Volume
549,655.00
52W High
$23.11
52W Low
$1.39
PE Ratio
-0.31
JSPR Fundamentals
Price
$1.84
Prev Close
$1.87
Open
$1.86
50D MA
$2.06
Beta
1.09
Avg. Volume
418,584.84
EPS (Annual)
-$4.89
P/B
4.45
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Penny Stocks To Watch Now - December 2nd
Beyond Meat, Bitfarms, Fitell, Eventbrite, and Jasper Therapeutics are the five Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are low-priced shares of small...
MarketBeat·8d ago
News Placeholder
More News
News Placeholder
Jasper Stock Jumps After Promising New Asthma Study Results
Jasper Therapeutics released positive data from a study of subcutaneous briquilimab for allergic asthma treatment.read more...
Benzinga·10d ago
News Placeholder
JSPR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Jasper Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Jasper Therapeutics, Inc. (Jasper or the Company) (NASDAQ: JSPR) and reminds investors of the...
Business Wire·24d ago
News Placeholder
Deadline Soon: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz reminds investors of the upcoming November 18, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of...
Business Wire·25d ago
News Placeholder
JSPR DEADLINE: Faruqi & Faruqi Reminds Jasper Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 18 , 2025 - JSPR
JSPR DEADLINE: Faruqi & Faruqi Reminds Jasper Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 18 , 2025 - JSPR JSPR DEADLINE: Faruqi & Faruqi Reminds Jasper...
PR Newswire·28d ago
News Placeholder
JSPR Deadline: JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
JSPR Deadline: JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit JSPR Deadline: JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities...
PR Newswire·1mo ago
News Placeholder
JSPR Deadline: Rosen Law Firm Urges Jasper Therapeutics, Inc. (NASDAQ: JSPR) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, reminds investors there is a class action lawsuit on behalf of purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR), between...
Business Wire·1mo ago
News Placeholder
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Jasper Therapeutics
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Jasper Therapeutics, Inc. (Jasper or the Company) (NASDAQ: JSPR). Faruqi & Faruqi is a leading...
Business Wire·1mo ago
News Placeholder
JSPR Deadline: JSPR Investors with Losses in Excess of $100K Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit
JSPR Deadline: JSPR Investors with Losses in Excess of $100K Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit JSPR Deadline: JSPR Investors with Losses in Excess of $100K...
PR Newswire·1mo ago
News Placeholder
JSPR INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In JSPR To Contact Him Directly To Discuss Their Options
JSPR INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In JSPR To Contact Him Directly To Discuss Their Options JSPR...
PR Newswire·1mo ago

Latest JSPR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.